Literature DB >> 3147091

Cystic fibrosis in the United Kingdom 1977-85: an improving picture. British Paediatric Association Working Party on Cystic Fibrosis.

.   

Abstract

A national survey was conducted of patients with cystic fibrosis who were known to paediatricians, chest physicians, and others or whose deaths were reported through the death certification authorities in the United Kingdom during 1977 to 1985. From this population based study a revised incidence figure of one affected baby in 2500 live births was produced. Mortality was very high in the first year of life (7.6%) and was substantially greater for females than for males under age 20 years. A temporal improvement in mortality was found during the period under study, with about 100 more births than deaths occurring each year. This improvement was notable in the first five years of life. Meconium ileus, which used to be a primary cause of early mortality, is becoming increasingly rare as a cause of death. The total prevalence of cystic fibrosis in the UK in mid-1985 was estimated to be about 5000.

Entities:  

Mesh:

Year:  1988        PMID: 3147091      PMCID: PMC1835312          DOI: 10.1136/bmj.297.6663.1599

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  4 in total

1.  Life tables for cystic fibrosis.

Authors:  L George; A P Norman
Journal:  Arch Dis Child       Date:  1971-04       Impact factor: 3.791

2.  Cystic fibrosis mortality in England and Wales and in Victoria, Australia 1976-80.

Authors:  P Phelan; E Hey
Journal:  Arch Dis Child       Date:  1984-01       Impact factor: 3.791

3.  Playing with fire: an experiment in clinical budgeting.

Authors:  S M Lamb; T J David
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-23

4.  A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.

Authors:  M Corey; F J McLaughlin; M Williams; H Levison
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

  4 in total
  11 in total

1.  Peripheral nerve dysfunction in adult patients with cystic fibrosis.

Authors:  J I O'Riordan; J Hayes; M X Fitzgerald; J Redmond
Journal:  Ir J Med Sci       Date:  1995 Jul-Sep       Impact factor: 1.568

2.  Inferences for health provision from survival data in cystic fibrosis.

Authors:  P A Lewis
Journal:  Arch Dis Child       Date:  1998-10       Impact factor: 3.791

3.  Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs.

Authors:  J S Elborn; R J Prescott; B H Stack; M C Goodchild; J Bates; C Pantin; N Ali; D J Shale; M Crane
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

4.  High resolution computed tomography in cystic fibrosis: correlation with pulmonary function and assessment of prognostic value.

Authors:  P M Logan; R M O'Laoide; D Mulherin; S O'Mahony; M X FitzGerald; J B Masterson
Journal:  Ir J Med Sci       Date:  1996 Jan-Mar       Impact factor: 1.568

5.  Pseudomonas colonization in cystic fibrosis: lack of correlation with secretion of ABO blood group antigens.

Authors:  D Mulherin; M J Coffey; M J Keogan; P O'Brien; M X FitzGerald
Journal:  Ir J Med Sci       Date:  1990-07       Impact factor: 1.568

6.  Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study.

Authors:  R Mahadeva; K Webb; R C Westerbeek; N R Carroll; M E Dodd; D Bilton; D A Lomas
Journal:  BMJ       Date:  1998-06-13

7.  Cystic fibrosis: current survival and population estimates to the year 2000.

Authors:  J S Elborn; D J Shale; J R Britton
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

8.  Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre.

Authors:  J E Dankert-Roelse; G J te Meerman
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

9.  Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period.

Authors:  L T Weaver; M R Green; K Nicholson; J Mills; M E Heeley; J A Kuzemko; S Austin; G A Gregory; A E Dux; J A Davis
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

10.  Heart-lung transplantation for cystic fibrosis.

Authors:  M E Hodson
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.